Table 1.
Participant demographics and disease characteristics.
| ADS (n = 22) |
HAND (n = 22) |
Healthy Controls (n = 30) |
|
|---|---|---|---|
| Age (years) | 69.41 (4.84) | 58.68 (6.11) | 65.21 (7.23) |
| Sex | 12 Females/10 Males | 12 Females/10 Males | 15 Females/15 Males |
| ADS Severity | 11 AD/11 MCI | – | – |
| QDRS - Total | 5.80 (2.15) | – | – |
| QDRS - Cognitive | 2.73 (0.97) | – | – |
| QDRS - Behavioral | 3.07 (1.44) | – | – |
| PSQI Total | 4.09 (2.71) | – | 5.40 (2.67) |
| HAND Severity | – | 17 ANI/1 MND/4 HAD | – |
| CD4 Nadir (cells/μL) | – | 221.41 (144.95) | – |
| Current CD4 (cells/μL) | – | 828.55 (376.61) | – |
| Years Since HIV Diagnosis | – | 14.36 (8.06) | – |
| Years on cART | – | 12.05 (6.70) | – |
| Years without cART Treatment | – | 2.32 (3.47) | – |
Note. Means and standard deviations are displayed for each continuous variable, and counts are shown for each categorical variable. ADS – Alzheimer's Disease Spectrum, AD – Alzheimer's Disease, MCI – Mild Cognitive Impairment, QDRS – Quick Dementia Rating System, PSQI – Pittsburgh Sleep Quality Index, HAND – HIV-associated Neurocognitive Disorders, ANI – Asymptomatic Neurocognitive Impairment, MND – Mild Neurocognitive Impairment, HAD – HIV-associated Dementia, cART – Combination antiretroviral therapy.